BGF World Gold A2 vs UBS Lux Equity Fund Biotech USD

BGF World Gold A2 vs UBS Lux Equity Fund Biotech USD

1. BGF World Gold A2

  • Security

    BGF World Gold A2 USD

  • Fee

    2.48%

  • ISIN

    LU0055631609

  • Holdings

    8

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 12 holdings in BGF World Gold A2, where the largest holding is Newmont (5.87), followed by Barrick Gold (5.76) and Endeavour Mining (5.24). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in BGF World Gold A2 and UBS Lux Equity Fund Biotech USD.

BGF World Gold A2 UBS Lux Equity Fund Biotech USD
1. Newmont Corp
USA
5.87 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Barrick Gold Corp
Canada
5.76 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Endeavour Mining Plc
UK
5.24 %
3. Moderna Inc
9.21 %
4. Wheaton Precious Metals Corp
Canada
4.95 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Alamos Gold Inc
Canada
4.94 %
5. AbbVie Inc
USA
5.52 %
6. Northern Star Resources Ltd
Australia
4.7 %
6. Gilead Sciences Inc
USA
4.66 %
7. Lundin Gold Inc
Canada
4.19 %
7. Amgen Inc
4.32 %
8. Sprott Physical Silver Trust Units
Canada
4.19 %
8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.28 %

The list of fund holdings was last updated on April 17, 2025.